MicroRNA-126 expression and its mechanism of action in patients with systemic lupus erythematosus

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 20, 2015, Pages 3838-3842

  Liu, Y J ^a   Fan, W J ^a   Bai, J Z ^a  

^a TENGZHOU CENTRAL PEOPLE S HOSPITAL   (China)

Author keywords

Interferon; MicroRNA 126; Systemic lupus erythematosus

Indexed keywords

ALPHA INTERFERON; ISG56 MESSENGER RNA; MESSENGER RNA; MICRORNA 126; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MICRORNA; MIRN126 MICRORNA, HUMAN;

ARTICLE; CLINICAL RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; BLOOD; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; BIOMARKERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; MIDDLE AGED;

EID: 84966341107     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BEZALEL S, GURI KM, ELBIRT D, ASHER I, STHOEGER ZM. Type I interferon signature in systemic lupus erythematosus. Isr Med Assoc J 2014; 16: 246-249.
2. LAUWERYS BR, DUCREUX J, HOUSSIAU FA. Type I interferon blockade in systemic lupus erythematosus: where do we stand? Rheumatology 2014; 53: 1369-1376.
3. LU J, GETZ G, MISKA EA, MISKA EA, ALVAREZ-SAAVEDRA E, LAMB J, PECK D, SWEET-CORDERO A, EBERT BL, MAK RH, FERRANDO AA, DOWNING JR, JACKS T, HORVITZ HR, GOLUB TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
4. XU M, XIE Y, SHENG W, MIAO J, YANG J. Adenovirusmediated ING4 gene transfer in osteosarcoma suppresses tumor growth via induction of apoptosis and inhibition of tumor angiogenesis. Technol Cancer Res Treat 2014; 14: 369-378.
5. ISFORT RJ, CODY DB, LOVELL G, DOERSEN CJ. Analysis of oncogenes, tumor suppressor genes, autocrine growth-factor production, and differentiation state of human osteosarcoma cell lines. Mol Carcinog 1995; 14: 170-178.
6. LUO JW, WANG X, YANG Y, MAO Q. Role of micro-RNA (miRNA) in pathogenesis of glioblastoma. Eur Rev Med Pharmacol Sci 2015; 19: 1630-1639.
7. JIANG X, KANDA T, WU S, NAKAMURA M, MIYAMURA T, NAKAMOTO S, BANERJEE A, YOKOSUKA O. Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity. World J Gastroenterol 2014; 20: 7197-7206.
8. LI X. MiR-375, a microRNA related to diabetes. Gene 2014; 533: 1-4.
9. WEI Y, NAZARI-JAHANTIGH M, NETH P, WEBER C, SCHOBER A. MicroRNA-126,-145, and-155: a therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 2013; 33: 449-454.
10. LIU Y, GAO G, YANG C, ZHOU K, SHEN B, LIANG H, JIANG X. The role of circulating microRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. Int J Mol Sci 2014; 15: 10567-10577.
11. BESSONE F, POLES N, ROMA MG. Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World J Hepatol 2014; 6: 394-409.
12. XU WD, PAN HF, LI JH, YE DQ. MicroRNA-21 with therapeutic potential in autoimmune diseases. Expert Opin Ther Targets 2013; 17: 659-665.
13. XU WD, LU MM, PAN HF, YE DQ. Association of MicroRNA-146a with autoimmune diseases. Inflammation 2012; 35: 1525-1529.
14. MENG S, CAO JT, ZHANG B, ZHOU Q, SHEN CX, WANG CQ. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J Mol Cell Cardiol 2012; 53: 64-72.
15. PALANICHAMY A, BAUER JW, YALAVARTHI S, MEEDNU N, BARNARD J, OWEN T, CISTRONE C, BIRD A, RABINOVICH A, NEVAREZ S, KNIGHT JS, DEDRICK R, ROSENBERG A, WEI C, RANGEL-MORENO J, LIESVELD J, SANZ I, BAECHLER E, KAPLAN MJ, ANOLIK JH. Neutrophilmediated IFN activation in the bone marrow alters B cell development in human and murine systemic lupus erythematosus. J Immunol 2014; 192: 906-918.
16. HUA J, KIROU K, LEE C, CROW MK. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006; 54:1906-1916.
17. NARWAL R, ROSKOS LK, ROBBIE GJ. Population pharmacokinetics of sifalimumab, an investigational anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus. Clin Pharmacokinet 2013; 52: 1017-1027.